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Rapidly cycling Lgr5+ stem cells are exquisitely
sensitive to extrinsic dietary factors that modulate
colon cancer risk
Eunjoo Kim1,2, Laurie A Davidson1,3, Roger S Zoh1,4, Martha E Hensel5, Michael L Salinas1,3, Bhimanagouda S Patil6,
Guddadarangavvanahally K Jayaprakasha6, Evelyn S Callaway1,3, Clinton D Allred3, Nancy D Turner3,6, Brad R Weeks5 and
Robert S Chapkin*,1,3,6,7
The majority of colon tumors are driven by aberrant Wnt signaling in intestinal stem cells, which mediates an efficient route toward
initiating intestinal cancer. Natural lipophilic polyphenols and long-chain polyunsaturated fatty acids (PUFAs) generally suppress
Wnt- and NF-κB- (nuclear factor-κ light-chain enhancer of activated B-cell) related pathways. However, the effects of these extrinsic
agents on colonic leucine-rich repeat-containing G-protein-coupled receptor 5-positive (Lgr5+) stem cells, the cells of origin of
colon cancer, have not been documented to date. Therefore, we examined the effect of n-3 PUFA and polyphenol (curcumin)
combination on Lgr5+ stem cells during tumor initiation and progression in the colon compared with an n-6 PUFA-enriched control
diet. Lgr5-EGFP-IRES-creERT2 knock-in mice were fed diets containing n-6 PUFA (control), n-3 PUFA, n-6 PUFA+curcumin or n-3
PUFA+curcumin for 3 weeks, followed by 6 azoxymethane (AOM) injections, and terminated 17 weeks after the last injection. To
further elucidate the effects of the dietary bioactives at the tumor initiation stage, Lgr5+ stem cells were also assessed at 12 and
24 h post AOM injection. Only n-3 PUFA+curcumin feeding reduced nuclear β-catenin in aberrant crypt foci (by threefold)
compared with control at the progression time point. n-3 PUFA+curcumin synergistically increased targeted apoptosis in DNA-
damaged Lgr5+ stem cells by 4.5-fold compared with control at 12 h and maximally reduced damaged Lgr5+ stem cells at 24 h,
down to the level observed in saline-treated mice. Finally, RNAseq analysis indicated that p53 signaling in Lgr5+ stem cells from
mice exposed to AOM was uniquely upregulated only following n-3 PUFA+curcumin cotreatment. These novel findings
demonstrate that Lgr5+ stem cells are uniquely responsive to external dietary cues following the induction of DNA damage,
providing a therapeutic strategy for eliminating damaged Lgr5+ stem cells to reduce colon cancer initiation.
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Numerous epidemiological studies have established strong
evidence that many cancers including colon cancer have
substantial risk proportions attributed to extrinsic factors such
as diet, smoking and obesity.1 High fat diet (HFD)-induced
obesity augments stemness and tumorigenicity of intestinal
progenitors.2 In addition, epithelial colonic leucine-rich repeat-
containing G-protein-coupled receptor 5-positive (Lgr5)+ stem
cells respond to HFD3 and genotoxic carcinogen, for example,
AOM,4 during the cancer initiation stage. It has also been
demonstrated that colonic Lgr5+ stem cells are preferentially
damaged by AOM compared with differentiated cells.4 A
functional consequence of this status could enhance tumor-
igenesis. Thus, induction of apoptosis in DNA-damaged Lgr5+
stem cells is likely to be a useful marker for successful cancer
prevention, and may hold promise for identifying novel and
improved cancer-chemopreventive agents. For example, it
has been shown that nonsteroidal anti-inflammatory drugs
(NSAIDs) can induce apoptosis in Lgr5+ stem cells and
suppress adenoma formation in APCMin/+ mice.5 Long-term
use of NSAIDs, in particular COX-2-specific inhibitors, is
associated with side effects, which has stimulated the
development of new targets and combination strategies for
cancer chemoprevention.6
It is clear that select extrinsic bioactives, for example, n-3
polyunsaturated fatty acids (n-3 PUFAs) and curcumin (Cur),
independently reduce aberrant crypt foci (ACF) and polyp
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formation in humans7,8 and combinations of the two have been
reported to exert synergistic effects related to the suppression
of chronic inflammation and cell proliferation and the promo-
tion of apoptosis in breast and pancreatic cancers.9–13 From a
mechanistic perspective, the combination of n-3 PUFA and
curcumin has been shown to suppress NF-κB (nuclear factor-κ
light-chain enhancer of activated B cell) activation in mouse
colonic mucosa,10 in part, by altering plasma membrane
composition,14 which is required for activation of the apoptotic
pathways.15 The suppression of inflammatory mediators such
as COX-2, inducible nitric oxide synthase, prostaglandin E2, 5-
lipoxygenase and cytosolic phospholipase A2 has also been
linked to the synergistic action of curcumin and n-3 PUFA, for
example, docosahexaenoic acid (DHA).11,12
DHA and curcumin synergistically induce p53 activation,9,13
a well-known tumor suppressor.16 This is noteworthy because
p53 functions, in part, to inhibit NF-κBactivity, thereby inducing
apoptosis in human colon cancer cells.17 In contrast, the
loss of p53 during tumor progression promotes an NF-κB-
dependent inflammatory microenvironment,18 which is a
critical event in the commitment of stem cells to apoptosis
following DNA damage.19,20 Unfortunately, the properties of
extrinsic chemoprotective natural compounds known to
enhance the p53 signaling pathway in colonic adult stem cells
from the perspective of cancer initiation and progression have
not been determined.
In this study, we assessed the chemoprotective effects of diet
on Lgr5+ stem cell homeostasis in the context of AOM-induced
tumorigenesis at both the initiation and pretumor stages. Our
novel data provide evidence that curcumin combined with n-3
PUFA synergistically reduces AOM-induced nuclear β-catenin
levels in ACF, in part, by promoting p53-dependent signaling
and targeted apoptosis in damaged Lgr5+ stem cells at the
initiation stage. We also provide evidence that DNA-damaged
Lgr5+ stem cells are highly responsive to the combination diet
compared with DNA-damaged differentiated cells. Our findings
demonstrate for the first time that rapidly cycling Lgr5+ stem
cells are exquisitely sensitive to extrinsic dietary factors which
modulate colon cancer risk.
Results
n-3 PUFA and curcumin synergize to promote targeted
apoptosis of damaged Lgr5+ stem cells at the tumor
initiation stage. To elucidate the unique properties of
colonic Lgr5+ stem cells in terms of their response to
bioactive compounds in the presence of carcinogen, we
used mice carrying a gene for enhanced green fluorescent
protein (EGFP) knocked into the Lgr5 genomic locus.24 Mice
were fed with n-3 PUFA and curcumin alone or in combina-
tion for 3 weeks, injected with AOM and analyzed to measure
DNA damage (gamma H2AX (γH2AX)), apoptosis (terminal
deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL)), damage repair (methylguanine-methyl transferase
(MGMT)) and proliferation (5-ethynyl-2′-deoxyuridine (EdU))
in crypts 12 and 24 h later as described previously.4 Because
the integration cassette in this mouse model is epigenetically
silent in about 60–70% of crypts,25 we analyzed only GFP-
positive crypts using fluorescence microscopy. No differences
between GFPhigh and GFPneg crypts in response to carcino-
gen and bioactive compounds were observed (data not
shown). In a separate experiment, levels of n-3 PUFA, n-6
PUFA and curcumin incorporated into colonic crypts were
assessed following a 3-week feeding period (Supplementary
Figure 1F). The data demonstrate that these bioactives were
readily incorporated into the target site.
It has been demonstrated that Lgr5+ stem cells are
preferentially damaged by AOM in the distal colon compared
with differentiated cells4 and n-3 PUFA reduce AOM-induced
DNA adducts,26 which cause double-strand breaks (DSBs).4
Therefore, to determine the chemoprotective effects of combi-
natorial bioactives on AOM-induced DNA damage in Lgr5+
stem cells as compared with differentiated cells in vivo, we
measured γH2AX, a marker of the double-strand breaks. As
shown in Figure 1a, the level of DNA-damaged stem cells at
12 h in both n-3 PUFA and n-3 PUFA+curcumin treatmentswas
50% lower compared with the n-6 PUFA. In comparison, DNA
damage in n-6 PUFA+curcumin was 33% lower compared with
n-6 PUFA-fed mice. Strikingly, by 24 h, the n-3 PUFA+curcumin
group maximally decreased damaged Lgr5+ stem cells, that is,
the level was not different from the saline-injected mice.
The deletion of damaged Lgr5+ stem cells, the cells of origin of
colon cancer,21 is a critical mechanism to prevent tumorigenesis
in the intestine.5 As n-3 PUFA27 and curcumin28 promote
apoptosis in 1,2-dimethylhydrazine or AOM-injected rats, we
next investigated the synergistic effects of n-3 PUFA+curcumin
on the Lgr5+ stem cell acute DNA damage response. Figure 1b
shows representative colocalization images of DNA-damaged
(γH2AX, white) Lgr5+ stem cells (GFP, green) with apoptosis
(TUNEL, red), DNA repair (MGMT, red) or cell proliferation (EdU,
red). As shown in Figure 2a, immediately following AOM
exposure, n-3 PUFA and curcumin either alone or in combination
increased apoptosis 41.5-fold in Lgr5+ stem cells (open
symbols) at 12 h compared with n-6 PUFA, whereas the
apoptotic response was significantly lower in differentiated cells
across all groups (filled symbols). Next, using a simple linear
regression analysis, we determined whether there is any
association between AOM-induced apoptosis and AOM-
induced damage. As shown in Figure 2b (left), n-3 PUFA
+curcumin (slope=0.65) and n-6 PUFA (slope=0.61) exhibited
a significant proportional increase in apoptosis in Lgr5+ stem
cells in response to DNA damage at 12 h. However, n-3 PUFA
+curcumin exhibited o40% of damaged (γH2AX+) Lgr5+ stem
cells per crypt (DNA damage index), whereas n-6 PUFA had 40–
80% of damaged Lgr5+ stem cells per crypt. These data suggest
that Lgr5+ stem cells responded efficiently to n-3 PUFA
+curcumin treatment in the presence of DNA damage by
inducing apoptosis, whereas differentiated cells were not
responsive (small symbols within the dotted line). We subse-
quently quantified the number of damaged Lgr5+ stem cells that
were targeted for apoptotic deletion, that is, GFP+, TUNEL+,
γH2AX+ triple-positive cells, as the selective deletion of damaged
Lgr5+ stem cells through apoptosis could mitigate the clonal
expansion of damaged Lgr5+ stem cells. As shown in Figure 2c
(right), 62% of DNA-damaged Lgr5+ stem cells were deleted by
apoptosis in n-3 PUFA+curcumin-treated mice at 12 h, which
was fivefold higher than the n-6 PUFA group. Importantly, n-3
PUFA and curcumin interaction was only detected in Lgr5+ stem
cells (P=0.025) and not in differentiated cells (P=0.526)
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(Supplementary Tables 1A and B). These novel findings
demonstrate that DNA-damaged Lgr5+ stem cells uniquely
respond to n-3PUFAand curcumin, and n-3PUFAand curcumin
synergize to promote the deletion of DNA-damaged Lgr5+ stem
cell by enhancing targeted apoptosis.
AOM-induced MGMT expression is enhanced by n-3
PUFA and/or curcumin in damaged Lgr5+ stem cells
and differentiated cells. The major pathway to remove
AOM-induced O6-methylguanine (O6meG) DNA adducts is
via MGMT. Therefore, the expedited elimination of O6meG by
Figure 1 Effect of n-3 PUFA and curcumin on AOM-induced DNA DSBs in mouse colonic crypts at 12 and 24 h post AOM injection. (a) Comparison of γH2AX+ (DNA-
damaged) stem and differentiated cells in the distal colon of saline (control) and 12 and 24 h post AOM-injected mice (left). GFP+ crypts from n= 8 to 9 mice at 12 h, and n= 3 for
saline and 24 h were counted. Statistically significant differences between diets and treatments were determined using two-way analysis of variance (ANOVA), followed by Tukey’s
multiple comparison test adjustment. Different letters indicate significant differences between treatment groups in each time (Po0.05). Means and standard errors of the mean
(S.E.M.) in different cell types, diets and treatments are listed in the table (right). Diets are labeled with different symbols and the open symbols refer to stem cells, whereas filled
symbols refer to differentiated cells. (b) Representative images (objective, × 40) of GFP+ (Lgr5 stem cells, green), γH2AX+ (DNA DSBs, white) and TUNEL+ (apoptotic body, red)
cells 12 h after AOM. Representative images of MGMT+ (DNA damage repair, red) and EdU+ (cell proliferation, red) cells 24 h following AOM exposure. Saline-injected animals
serve as the control. n-6, n-6 PUFA; n-6+Cur, n-6 PUFA+curcumin; n-3, n-3 PUFA; n-3+Cur, n-3 PUFA+curcumin
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increasing MGMT activity is likely to be a successful chemo-
prevention strategy. Because curcumin induces MGMT
protein expression in colon cancer cells, we estimated
MGMT activity using quantitative immunohistochemical
analysis.4 As shown in Figure 3a, MGMT expression in
Lgr5+ stem cells was maximally induced by curcumin with
either PUFA diet or the n-3 PUFA treatment at 24 h as
compared with saline treatment. However, only n-3 PUFA
Figure 2 Effect of n-3 PUFA and curcumin on AOM-induced apoptosis in mouse colonic crypts at 12 and 24 h post AOM injection. (a) Comparison of TUNEL+ (apoptotic)
stem and differentiated cells in the distal colon of saline, and 12 and 24 h post AOM-injected mice (left). Refer to Figure 1a legend for animal number and statistical details.
Different letters indicate significant (Po0.05) differences between treatment groups at each time point. (b) Association between AOM-induced apoptotic cells and γH2AX+ cells in
stem and differentiated cells at 12 h (left) and 24 h (right). Each point represents an individual animal and diets are labeled with different symbols as indicated in the Table in A.
Slopes shown are found to be significantly different from 0 at a significant level of 0.05 (n-3 PUFA+Cur and n-6 PUFA stem cells, 12 h). Data from differentiated cells (12 and 24 h)
and stem cells (24 h) are highlighted within the dotted lines and solid lines, respectively, instead of showing slope, as none of the slopes differed from zero. Linear regression was
performed using GraphPad Prism 6.0. Values represent Pearson's correlation coefficients, r, ranges from − 1 to +1. P-values were calculated using an F-test. Apoptotic
index= no. of TUNEL+ stem or differentiated cells/total no. of stem or differentiated cells per crypt x100 at 12 and 24 h post AOM injection; damage index= no. of γH2AX+ stem or
differentiated cells/total no. of stem or differentiated cells per crypt x100 at 12 and 24 h post AOM injection. (c) Percentage of non-targeted apoptosis (no. of TUNEL+ and γH2AX−
stem or differentiated cells/total no. of γH2AX− stem or differentiated cells x100) at 12 h post AOM injection (left). Percentage of targeted apoptosis (no. of double-positive TUNEL+
and γH2AX+ stem or differentiated cells/total no. of γH2AX+ stem or differentiated cells x100) at 12 h post AOM injection (right). Refer to Figure 1a legend for animal numbers and
statistics. Bars that do not share the same letter are significantly different (Po0.05). n-6, n-6 PUFA; n-6+Cur, n-6 PUFA+curcumin; n-3, n-3 PUFA; n-3+Cur, n-3 PUFA+curcumin
Eunjoo Kim et al
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+curcumin-fed animals exhibited an induction in MGMT
associated with DNA damage in Lgr5+ stem cells at 24 h
using a simple linear regression analysis (Figure 3b, right). In
contrast, in differentiated cells (filled symbol), no significant
induction was detected at 24 h (Figure 3a). As shown in
Figure 3b (left), at 12 h post AOM exposure, n-3 PUFA and
n-6 PUFA+curcumin proportionally increased MGMT expres-
sion in Lgr5+ stem cells (n-3 PUFA: slope= 2.07, r= 0.92 and
n-6 PUFA+curcumin: slope= 0.83, r=0.90), compared with
n-3 PUFA and n-3 PUFA+curcumin treatment induction of
MGMT in differentiated cells (GFPneg) (Figure 3b, middle).
We subsequently quantified the number of damaged Lgr5+
Figure 3 Effect of n-3 PUFA and curcumin on AOM-induced MGMTexpression in mouse colonic crypts at 12 and 24 h post AOM injection. (a) Comparison of MGMT+ (DNA
damage repairing) stem and differentiated cells in the distal colon of saline and 12 and 24 h post AOM-injected mice (left). GFP+ crypts were scored from n= 3 per diet in saline-
treated mice; n= 5–6 per diet in AOM-injected mice at 12 and 24 h. Refer to Figure 1a legend for statistical details. Different letters indicate significant (Po0.05) differences
between treatment groups at each time point. (b) Association between AOM-induced MGMT-expressing cells and γH2AX+ cells in stem and differentiated cells at 12 h (left and
middle) and 24 h (right). Each point represents an individual animal and diets are labeled with different symbols as indicated in the table in (a). Slopes shown are found to be
significantly different from 0 at a significant level of 0.05. Data from differentiated cells (24 h) are highlighted within the dotted line instead of showing slope because none of the
slopes differed from zero. DNA repair index= no. of MGMT+ stem or differentiated cells/total no. of stem or differentiated cells per crypt x100 at 12 and 24 h post AOM injection;
damage index= no. of γH2AX+ stem or differentiated cells/total no. of stem or differentiated cells per crypt x100 at 12 and 24 h post AOM injection. Refer to Figure 2b legend for
statistical details. (c) Percentage of undamaged cells expressing MGMT (no. of MGMT+ and γH2AX− stem or differentiated cells/total no. of γH2AX− stem or differentiated cells
x100) at 24 h post AOM injection (left). Percentage of cells expressing MGMT in damaged cells (no. of double-positive MGMT+ and γH2AX+ stem or differentiated cells/total no. of
γH2AX+ stem or differentiated cells x100) at 24 h post AOM injection (right). Refer to Figure 1a legend for statistical details. Bars that do not share the same letter are significantly
different (Po0.05). n-6, n-6 PUFA; n-6+Cur, n-6 PUFA+curcumin; n-3, n-3 PUFA; n-3+Cur, n-3 PUFA+curcumin
Eunjoo Kim et al
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stem cells that were targeted for damage repair, that is,
GFP+, MGMT+, γH2AX+ triple-positive cells, as the deletion of
O6meG in Lgr5+ stem cells by MGMT could mitigate the
clonal expansion of DNA-damaged Lgr5+ stem cells. As
shown in Supplementary Figure 3B (12 h) and Figure 3c
(right, 24 h), n-3 PUFA+curcumin and n-3 PUFA induced
MGMTexpression in damaged Lgr5+ stem cells as compared
with n-6 PUFA. Additionally, damaged differentiated cells also
induced MGMT expression, similar to damaged Lgr5+ stem
cells both at 12 and 24 h (Supplementary Figures 3B and C).
Crypt regeneration following AOM exposure. As shown in
Figure 1b, proliferating cells were predominantly located at
the bottom of crypt where Lgr5+ stem cells and transit
amplifying (TA) cells reside, together referred to as the stem
cell clonogen compartment.29 To assess dietary effects on
stem cell proliferation, a requirement for crypt regeneration
following insult, EdU+ cells in the colonic crypt were
quantified following AOM-induced DNA damage. The per-
centage of proliferating cells at 12 h post AOM versus saline
injection was not affected across all dietary treatments
(Supplementary Figure 2A). An increase in cell division at
24 h was only associated with Lgr5+ stem cells, that is, not in
differentiated TA cells (Supplementary Figure 2A). These
findings indicate that colonic Lgr5+ stem cells uniquely
respond to cues associated with tissue homeostasis. There
was no significant association between the proliferative index
and the level of DNA damage (Supplementary Figure 2B) and
no diet effects were observed with regard to cell proliferation
in damaged Lgr5+ stem cells at 12 h (Supplementary
Figure 3C) and 24 h (Supplementary Figure 2C). Typically,
DNA-damaged stem cells in the gut undergo cell cycle arrest
and/or apoptosis via p53-mediated signaling.30,31 Therefore,
our inability to detect a decrease in cell cycle activity may
have been because of the fact that in the C57BL/6 mouse
model, proliferation kinetics rebound by ~ 12 h following
intestinal carcinogen exposure.30
Lgr5+ stem cell markers are enhanced by carcinogen
exposure. To further elucidate the effects of n-3 PUFA
+curcumin in the presence of AOM on Lgr5+ stem cells,
global transcriptional differences in early response genes
between sorted GFPhigh (Lgr5+) and GFPneg (differentiated)
cells were assessed by RNA sequencing. Mice were fed with
the combination of n-3 PUFA and curcumin or control diet
(n-6 PUFA) for 3 weeks, injected with AOM or saline and
killed 12 h later. Table 1 demonstrates that GFPhigh cells
expressed high levels of Lgr5 and other stem cell markers, for
example, Ascl2 and CD44, whereas GFPneg cells expressed
high levels of progenitor cell markers, for example, Reg4 and
Muc2, as well as Krt20 and Slc26a3 (Table 1). Surprisingly,
mRNA levels of crypt base columnar (CBC) cell marker
genes39 were rapidly altered by extrinsic factors (Table 2). For
example, CD44 mRNA levels in GFPhigh cells were increased
by 5.41-fold (in n-6 PUFA) and 2.88-fold (in n-3 PUFA
+curcumin) upon AOM exposure, and the enhancement was
significantly higher (1.87-fold) in n-6 PUFA versus n-3 PUFA
+curcumin-fed mice. Msi1 and Agr3 expression was unde-
tectable in GFPhigh cells isolated from control mice fed n-6
PUFA and treated with saline. In contrast, AOM exposure
resulted in the upregulation of Msi1 and Agr3 by 94.92- and
108.51-fold, respectively.
Differentiated cell markers were also modulated by extrinsic
factors. For example, Agr2, mainly expressed in progenitor
cells, was increased by AOM (1.62-fold) only inGFPhigh cells in
n-6 PUFA-fed mice (FDRo0.05). This finding is relevant
because elevated blood mRNA levels of Agr2 and Lgr5 are
associated with poor outcome in patients with colorectal
cancer.40 It is also noteworthy that in GFPhigh cells from mice
fed n-3 PUFA+curcumin, the expression of Prom1/CD133, a
colon cancer stem cell marker,41 and Cdx2, a prognostic
biomarker in stage II and stage III colon cancer,42 were not
modulated by AOM (Table 2).
Dietary fish oil and curcumin synergistically enhance p53
signaling in stem cells following AOM exposure. RNAseq
was used to identify signaling pathways that were most
significantly modulated by extrinsic cues. From a global
transcriptome perspective, GFPhigh stem cells from n-3 PUFA
+curcumin versus n-6 PUFA- (control) fed mice treated with
AOM exclusively increased p53, BRCA1 and Polo-like
kinase-related pathways (z-score41.96) (Figure 4a). This is
relevant because rapid accumulation of p53 is associated
with cell death in human colon cancer cells.43 A total of 24
p53 target genes were increased by extrinsic factors in
GFPhigh and GFPneg cells (Figure 4b). Of the 11 genes
uniquely increased by n-3 PUFA+curcumin in GFPhigh cells,
Bax was increased 3.53-fold (Figure 4c). This is noteworthy
because human embryonic stem cells (hESCs) have
constitutively active Bax at the Golgi, and active Bax
translocates from Golgi to mitochondria after DNA damage
in a p53-dependent manner, triggering a rapid apoptotic
response.19 To examine whether the increase in mRNA
expression was accompanied by enhanced expression at the
protein level, we quantified total Bax expression in Lgr5+ stem
cells and differentiated cells in n-6 PUFA versus n-3 PUFA
+curcumin-fed mice in the presence of AOM. As shown in
Figure 4d, the relative expression of total Bax in GFPhigh/
GFPneg cells was increased 1.3-fold by the administration of
n-3 PUFA+curcumin at 12 h post AOM exposure and
persisted for up to 24 h (1.5-fold). In contrast, in n-6 PUFA-
fed mice, total Bax in GFPhigh/GFPneg cells was unresponsive
at 12 h, and increased 1.3-fold at 24 h post AOM injection.
n-3 PUFA and curcumin combination reduces nuclear β-
catenin levels in ACF. Intestinal ACF formation is a
surrogate marker of colon cancer both in rodent preclinical
models and patients.44 Nuclear-to-cytoplasmic β-catenin
levels are associated with higher mortality in selected groups
of colorectal cancer patients45 and β-catenin accumulated
crypts serve as a premalignant biomarker.46 As shown in
Figure 5a (left), n-3 PUFA± curcumin groups exhibited a
significant reduction in the number of ACF per mouse
compared to n-6 PUFA and n-3 PUFA+curcumin-treated
mice exhibited a significant reduction (75%) in the incidence
of ACF as compared with n-6 PUFA (100% ACF incidence).
Figure 5b shows representative images of cross-sectioned
ACF (yellow boxes) and Figure 5c shows β-catenin expres-
sion (red) in serial cross-sections of the same ACF.
Subsequently, nuclear-to-cytosolic β-catenin expression was
Eunjoo Kim et al
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measured as a biomarker of cancer risk (Figure 5d).
β-Catenin was predominantly localized to the plasma
membrane region of normal colonocytes and negligible
nuclear β-catenin was detectable in colonic crypt cells in
saline-injected animals. In contrast, β-catenin immunoreac-
tivity was present in both the cytoplasm and the nucleus in
ACF-localized cells as expected46 (Figure 5c). Surprisingly,
only the n-3 PUFA+curcumin combination treatment exhibited
an inhibitory effect (Figure 5d), that is, reduced relative
density of nuclear/cytosolic β-catenin expression in ACF (n-3
PUFA× curcumin interaction, Po0.05) (Supplementary Table
1C). These data indicate that n-3 PUFA+curcumin synergis-
tically suppressed Wnt signaling in ACF, which may underlie
the molecular mechanism of n-3 PUFA and curcumin action
in the AOM-induced colon cancer model. Unfortunately, the
percentage of GFP+ Lgr5 cells within the ACF could not be
determined due to the mosaic nature of expression in the
Lgr5-EGFP-IRES-creERT2 knock-in mouse,25 that is, a large
fraction of ACF were GFP negative.
Discussion
There is an impending chronic disease crisis in our country
and it is predicted that if the current trends continue, the
number of cancer cases diagnosed annually by 2050 is likely
to double as a result of population aging.47 Heading off this
escalating burden of age-related illnesses requires an
emphasis on primary cancer prevention research and training
in cancer-related lifestyle decisions, including diet and
exercise.47 Here we describe the effect of beneficial
dietary factors on DNA damage-induced responses in Lgr5+
stem cells in the colon. Further justifying our investigation
is the fact that these bioactives do not exhibit the side
effects such as gastrointestinal bleeding and myocardial
complications associated with the administration of anticancer
drugs.6,48
DNA damage induced by AOM is directly linked to colon
tumorigenesis in the rodent model. To reduce the risk of
tumorigenic transformation of cells, it is critical that DNA-
damaged cells be deleted or repaired via MGMT. We have
previously demonstrated that colonic Lgr5+ stem cells are
highly impacted by AOM exposure, resulting in the promotion
of apoptosis and induction of MGMT expression compared
with differentiated cells during the first 12–24 h after AOM
exposure.4 In this study, we extend these findings by
demonstrating for the first time that n-3 PUFA+curcumin
combination maximally promotes targeted apoptosis
(Figure 2c) and the induction of MGMT expression in DNA-
damaged Lgr5+ stem cells (Figure 3b). Consistent with this
observation, it has been reported that n-3 PUFA-enriched
diets enhance targeted apoptosis during colon tumor initiation,
in part, by downregulating Bcl-2.27 In addition, n-3 PUFA may
prime colonocytes for damage-induced apoptosis by enhan-
cing the unsaturation of mitochondrial phospholipids, resulting
in an increase in oxidative stress and the initiation of the
apoptotic cascade.49,50 Curcumin can also induce apoptosis
by activating mitochondria-initiated apoptotic pathways.51
Interestingly, the combination of DHA and curcumin has an
additive effect with regard to the induction of apoptosis in
breast cancer and pancreatic cell lines.9,12 With respect toTa
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Cell Death and Disease
Table 2 Marker genes transcriptionally modulated by extrinsic factors
Abbreviations: AOM, azoxymethane; FDR, false discovery rate; GFP, green fluorescent protein; PUFA, polyunsaturated fatty acid; TA, transit amplifying.
Fold change of marker gene expression in colonic GFPhigh andGFPneg cells in the presence of (A) carcinogen (12 h) and (B) bioactive treatments, n= 4mice per group.
FDR valueso0.05 are given three asterisks (***), FDR valueso0.1 are given two asterisks (**), FDR valueso0.2 are given one asterisk (*) and any FDR values40.2
are marked with a dash (—)
Eunjoo Kim et al
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Figure 4 Lgr5+ stem cells exclusively enhance p53 signaling pathway by n-3 PUFA+Cur in the presence of AOM. (a) Canonical pathways in cells induced by n-6 PUFA or n-3
PUFA+Cur in the presence of AOM. (b) P53-associated genes induced by different groups. (c) Genes downstream of p53 in GFPhigh cells uniquely increased by n-3 PUFA+Cur in
the presence of AOM. FDR valueso0.05 are designated by three asterisks (***), FDR valueso 0.1 are designated by two asterisks (**), FDR valueso0.2 are designated by
one asterisk (*) and any FDR values40.2 are marked with a dash (− ). (d, left) Total Bax abundance in cells in n-6 PUFA and n-3 PUFA+Cur. Values were normalized to each
respective saline (control) group. *Significant difference between treatment groups (Po0.05). (Right) Representative image of Bax-positive (red) cells at 12 h and 24 h post AOM
exposure. Green dots indicate the location of GFP-positive Lgr5 stem cells. Saline-injected animals serve as the control. n-6, n-6 PUFA; n-6+Cur, n-6 PUFA+curcumin; n-3, n-3
PUFA; n-3+Cur, n-3 PUFA+curcumin
Eunjoo Kim et al
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Lgr5+ stem cell proliferation, only a mild increase was
observed at 24 h post AOM as compared with saline. This
finding is consistent with the fact that the crypt must
regenerate following the loss of cells in the crypt bottom after
carcinogen and radiation exposure.29
Only mice treated with the combination of n-3 PUFA
+curcumin exhibited an induction of p53 signaling exclusively
in Lgr5+ stem cells in the presence of AOM. This was
exemplified, in part, by the induction of Bax at the mRNA
and protein levels, a major mediator of p53-mediated
Figure 5 Chemoprotective effects of n-3 PUFA and curcumin on ACF incidence and the subcellular localization of β-catenin in ACF. (a, left) Percentage of mice with colonic
ACF as affected by diet and (right) the number of ACF per animal (half colon) in the presence of AOM. ACF from n= 7–8 mice were counted 17 weeks after six AOM injections.
Bars that do not share the same letter are significantly different (Po0.05). (b) H&E-stained tissues showing distinct colonic ACF in the center of the image with normal crypts at
the periphery in the presence of AOM compared with saline. (c) Immunofluorescent images of β-catenin (red) in serially sectioned ACF tissue. Nuclear staining was detected by
counterstaining cells with DAPI (blue). (d, left) Quantification of β-catenin expression (staining density) in nucleus/cytoplasm in ACF from mice on the four different diets. Values
were normalized to the n-6 PUFA (control) group. (Right) Representative image of β-catenin (red) translocated into the nucleus in a n-6 PUFA versus n-3 PUFA+Cur-fed mouse.
Magnified image of β-catenin in the nucleus (nuclear DAPI staining is circled). Refer to Figure 1a legend for statistical details. *Significant difference between treatment groups
(Po0.05). n-6, n-6 PUFA; n-6+Cur, n-6 PUFA+curcumin; n-3, n-3 PUFA; n-3+Cur, n-3 PUFA+curcumin
Eunjoo Kim et al
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apoptosis. These findings are relevant in view of the fact that
hESCs have constitutively active Bax at the Golgi and are
primed to undergo rapid apoptosis in a p53-dependent
manner.19 It has also been demonstrated that the absence
of an acute apoptotic response to AOM in p53-deficient mice is
associated with an increased tumor incidence.20,52 Further
studies are needed to elucidate the combinatorial effects of
diet on the translocation of active Bax from Golgi to
mitochondria. Consistent with these observations, curcumin
combined with n-3 PUFA synergistically reduced AOM-
induced nuclear β-catenin levels in ACF at the pretumor
stage. This is noteworthy because elevated nuclear β-catenin
levels are associated with higher mortality in selected groups
of colorectal cancer patients,45,53 and various attempts have
been made to identify and characterize pharmacological
inhibitors of β-catenin.54 Consistent with this notion, it has
been shown that n-3 PUFA inhibits nuclear location of
β-catenin in colon cancer cells.55
The potential benefits of using a combination of pleiotropic
chemoprotective compounds may also be linked to their
combined ability to suppress NF-κB activation, which drives
COX-2 expression.14 In terms of disease progression, COX-2
is capable of enhancing cell proliferation, angiogenesis, cell
migration and invasion, as well as inhibiting apoptosis and
enhancing tumor growth via cross-talk between Frizzled and
the epidermal growth factor receptor (EGFR).56 In addition,
both DHA and curcumin are capable of modulating plasma
membrane structure and EGFR function,57,58 which regulates
colon cancer stem cell proliferation. Curcumin can also inhibit
the expression of EGFR in human colon cancer cells.57
In summary, our data broaden and redefine the phenotypic
features of the colonic adult stem cell in the presence of
external cues. DNA-damaged Lgr5+ stem cells uniquely
respond to the combination of n-3 PUFA and curcumin, which
promote targeted apoptosis, in part, by enhancing p53
signaling and maximally reducing nuclear β-catenin in ACF.
This is a critical area of research because long-lived Lgr5+
stem cells are responsible for maintaining and regenerating
intestinal crypts.29 These novel findings demonstrate that
Lgr5+ stem cells are uniquely responsive to external dietary
cues following the induction of DNA damage during tumor
initiation and progression, providing a therapeutic strategy for
eliminating damaged stem cells and reducing colon
cancer risk.
Materials and Methods
Animals and study design. The animal use protocol was approved by the
University Animal Care Committee of Texas A&M University and conformed to NIH
guidelines. Lgr5-EGFP-IREScreERT2 knock-in mice,21 6–7 weeks old, were
acclimated for 1 week and then maintained on a semipurified diet
(Supplementary Figure 1A) for 3 weeks before injection with AOM (Sigma, St.
Louis, MO, USA; 10 mg/kg body weight). Mice were injected with AOM once a week
for 6 weeks and killed by CO2 asphyxiation at 17 weeks (n= 7–8 per group) after
the last AOM injection (Supplementary Figure 1B). In complementary experiments,
mice were injected with a single dose of AOM and killed 12 (n= 8) or 24 h (n= 8)
later (Supplementary Figure 1C). Control mice (n= 3) received a single saline
injection. Mice were injected with EdU (Life Technologies, Grand Island, NY, USA)
2 h before killing. Immediately after termination, the distal (3 cm proximal to the
anus) colon was rapidly removed, flushed with ice-cold saline and a longitudinal
section of the distal colon was immediately fixed in 4% paraformaldehyde for
hematoxylin and eosin (H&E) staining and immunofluorescence analyses.
Diets. A complete diet containing 5% corn oil (containing n-6 PUFA) was used as
a baseline control, that is, contained no n-3 PUFA or curcumin. The control diet was
supplemented with 1% (w/w) curcumin (n-6 PUFA+curcumin) to determine the effect
of curcumin. A diet containing 4% (w/w) Menhaden fish oil (enriched in n-3 PUFA)
was used to assess the effect of n-3 PUFA alone, whereas a fish oil+curcumin (n-3
PUFA+curcumin) diet was used to determine the additive/synergistic effects of these
dietary bioactives. Both n-3 PUFA and n-3 PUFA+curcumin diets contained 1% corn
oil (w/w) to ensure that essential fatty acid requirements were met (Supplementary
Figure 1A). Mice were provided with fresh diet every day and the feeders were
removed and washed daily. Animals had free access to food and water at all times
and 24 h food intakes were measured after 1 week of receiving the diets
(Supplementary Figure 1D). Body weights were recorded each week
(Supplementary Figure 1E) and weight gain was not affected by the experimental
diets. The fatty acid composition of the diets was analyzed by gas chromatography
and the level of curcumin was quantified by 1H NMR. The fatty acid composition of
the crypt was quantified by gas chromatography and the level of curcumin was
quantified by HPLC.
In vivo DNA damage and repair measurement. Longitudinal sections
of paraffin-embedded colon sections (4 μm) were deparaffinized, rehydrated
through graded ethanol and stained with antibodies using standard procedures.
DNA double-strand breaks were measured by immunofluorescence using a rabbit
monoclonal phospho-γH2AX Ser139 antibody (9718; Cell Signaling, Danver, MA,
USA; dilution 1:200). Lgr5+ stem cells were labeled using goat polyclonal GFP
antibody (ab6673; Abcam, Cambridge, MA, USA; dilution 1:400) and O6meG DNA
adduct removal was estimated by the induction of O6-MGMT expression using a
mouse monoclonal MGMT antibody (ab54306, Abcam; prediluted). Secondary
antibodies were anti-rabbit Alexa 647 (711-605-152; Jackson ImmunoResearch,
West Grove, PA, USA; dilution 1:400) for γH2AX, anti-goat 488 (705-545-147;
Jackson ImmunoResearch) for GFP and anti-mouse Alexa 546 (A10036; Life
Technologies) for MGMT. Negative control slides were incubated without primary
antibody. The DNA damage (or repair) index was determined by dividing the
number of γH2AX+ (or MGMT+) cells by the total number of cells in each crypt
column and multiplying by 100.
Slide scoring of in vivo apoptosis. To investigate whether alkylating
agent-induced DNA damage resulted in apoptotic cell death in colonic Lgr5+ stem
cells, free 3′-OH DNA termini were labeled using the TUNEL procedure according
to the manufacturer’s recommendations using the TACS 2 TdT-Fluor In Situ
Apoptosis Detection Kit (4810-30-K and 4810-30-R; Trevigen, Gaithersberg, MD,
USA) and detected with Streptavidin-CY3 (438315; Life Technologies). Negative
control slides were incubated without TdT enzyme. The apoptotic index was
determined by dividing the number of apoptotic cells by the total number of cells in
the crypt column and multiplying by 100. To corroborate the frequency of epithelial
cells undergoing apoptosis, paraffin-embedded sections were also assessed by
H&E staining by a blinded pathologist with both assays showing similar results.
In vivo measurement of cell proliferation. To investigate the effects of
alkylating agent-induced DNA damage on cell cycle activity in colonic epithelial
cells, proliferating cells were measured using the Click-iT EdU Alexa Fluor 555
Imaging Kit (Life Technologies) as per the manufacturer’s instructions. Negative
control slides were incubated without Alexa Fluor. The proliferation index was
determined by dividing the number of proliferating cells by the total number of cells
in the crypt column and multiplying by 100.
In vivo measurement of Bax expression. To measure the chemopro-
tective effect of diet and carcinogen on Bax expression in the colon, Lgr5+ stem
cells were labeled using goat polyclonal GFP antibody (ab6673; Abcam; dilution
1:400) and rabbit monoclonal total Bax antibody (14796; Cell Signaling; dilution
1:400). Secondary antibodies were anti-goat 488 (705-545-147; Jackson
ImmunoResearch) for GFP and anti-rabbit Alexa 647 (711-605-152; Jackson
ImmunoResearch: dilution 1:400) for Bax. Negative control slides were incubated
without Alexa Fluor. For each high power field (objective, × 40), GFP-positive crypts
were assessed by defining regions of interest for analysis. GFP staining was used
to define the region of interest and to assess differentiated cells and stem cells
within a crypt. The ratio of Bax expression in Lgr5+ stem/differentiated cells was
determined using the NIS Image software, version 3.2 (Nikon, Melville, NY, USA).
Eunjoo Kim et al
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Image acquisition and analysis. All immunofluorescent images of colonic
crypts were captured using an inverted TE 300 Nikon Eclipse fluorescence
microscope equipped with × 40/1.30 Nikon Plan Fluor oil immersion objective and a
Photometrics Cool Snap EZ digital CCD camera and a SOLA external light source
(Nikon, Melville, NY, USA). Images were processed using the NIS Image software,
version 3.2 (Nikon). Greater than 40 GFP-positive crypts per animal in each
treatment group were examined by one reader. The number of animals used for
each assay is described in each figure legend.
Cell sorting and RNA sequencing. To examine the global transcriptome in
stem versus differentiated cells, isolated colonocytes from the distal colon were
sorted based on GFP expression using a Beckman Coulter MoFlo (Indianapolis, IN,
USA). Approximately 12 000 GFPhigh cells (stem cells) and 275 000 GFPneg cells
(differentiated cells) were sorted for each treated mouse. Consistent with previous
observations,22 ~ 98% of costained isolated colonocytes were epithelial cell
adhesion molecule (EpCam) positive (data not shown). Isolated total RNA (2 ng)
from each sample was subsequently prepared for sequencing using the NuGen
Ovation Single Cell RNAseq System (0342HV). Samples were sequenced for 75
cycles with single index reads on the NextSeq 500 (Illumina, San Diego, CA, USA).
Following the removal of all genes with CPM (counts per million reads) valueso1,
publicly available R software, EdgeR, was used to identify differentially expressed
genes. In total, 15 043 genes were queried to detect differentially expressed genes.
For computational purposes, the EdgeR program adjusts all zero counts to values
larger than zero, so log fold changes can be computed.
Ingenuity pathway analysis. Genes differentially expressed (FDRo 0.05)
in GFPhigh versus GFPneg cells were included in pathway and function analyses
using the Ingenuity software (ingenuity pathway analysis (IPA); Ingenuity Systems;
http://www.ingenuity.com). Statistical significance of the association between each
data set and the canonical pathway was determined based on two parameters: (1) a
ratio of the number of genes from the data set that map to the pathway divided by
the total number of genes that map to the canonical pathway, and (2) P-values
calculated using Fischer's exact test determining the probability that the association
between the genes in the data set and the canonical pathway is due to chance
alone. The upstream regulator analysis function of IPA was subsequently used to
identify potential transcriptional regulators that could explain the observed changes
in gene expression. The activation z-score was calculated to predict activation or
inhibition of transcriptional regulators based on published findings accessible
through the Ingenuity knowledge base. Regulators with a z-score 41.96 or
o− 1.96 were considered to be significantly activated or inhibited. Functions and
pathways with P-value o0.05 (Fischer’s exact test) were considered to be
statistically significant.
ACF quantification. Paraffin-embedded, H&E-stained distal colon sections
(4 μm) were examined for ACF by a veterinary pathologist. Photomicrographs were
taken at × 40. ACF were defined as crypts with more than one of the following
features: loss of polarity, nuclear atypia (enlarged nuclei, vesiculated chromatin,
crowding), mucin depletion and crypt multiplicity. Emphasis was placed on aberrant
crypt multiplicity as a cardinal change. The presence of ACF adjacent to lymphoid
follicles were not considered true ACF because proximity to lymphoid tissue may
promote changes related to inflammation. For this study, only crypts with criteria
matching Group C (dysplastic microadenomas, with enlarged, elongated and
sometimes stratified nuclei with loss of polarity, mucin depletion and dysplasia)23
were considered ACF. The number of ACF per section was quantified and the
location mapped using mm measurements from the slide corner. In addition,
complementary immunohistochemistry was performed to assess colabeling with
β-catenin.
β-Catenin subcellular localization in the nucleus and cytoplasm
in ACF. Serial sections were used to measure the subcellular localization of
β-catenin in ACF. To measure the ratio of nuclear-to-cytosolic β-catenin in ACF,
tissue was labeled using a mouse monoclonal β-catenin antibody (610154; BD
Transduction, San Joes, CA, USA; dilution 1:500). Secondary antibody was anti-
mouse Alexa 546 (A10036; Life Technologies). Nuclear staining was detected by
counterstaining cells with 4', 6-diamidino-2-phenylindole (DAPI) (P36935; Life
Technologies). Negative control slides were incubated without primary antibody. For
each high power field (objective, × 40), ACF areas stained with β-catenin and DAPI
were assessed by defining regions of interest for analysis. DAPI staining was used
to define the nuclear region of interest and to separate nuclear and cytoplasmic
staining within a cell. The ratio of nuclear-to-cytosolic β-catenin was measured
using the NIS Image software, version 3.2 (Nikon).
Statistics. Data were analyzed using two-way analysis of variance and the
estimated mean groups were subsequently compared using simple t-tests. ATukey's
approach was used to adjust the resulting P-values for multiple comparisons. The
significant comparisons were obtained based on the adjusted P-values o0.05.
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